OBJECTIVE: Use of percutaneous suture closure devices after catheter-based interventions is increasing. We recently have seen several severe femoral @entity281 after use of such devices. The purpose of this study was to examine the incidence, comorbid associations, and management of femoral @entity281 associated with percutaneous suture closure devices. METHODS: We retrospectively reviewed all @entity166 that occurred after 2223 consecutive cardiac catheterization procedures performed over 12 months in a university-affiliated community teaching hospital. Outcome variables included demographics, procedural details, @entity281 , type of arterial reconstruction required, mortality, and limb loss. RESULTS: During this study, 822 @entity1 received percutaneous suture devices. Infection developed in 6 @entity1 (0.7%). The incidence of @entity6 in the population undergoing percutaneous suture closure was 219 of 822 @entity1 (26.6%). Three comorbid conditions, noted in multiple @entity1 with @entity166 , included @entity6 , @entity28 , and placement of a percutaneous suture closure device within the past 6 months. @entity69586 developed in 4 @entity1 . Gram-positive cocci predominated in 4 @entity1 . In 1 @entity1 with @entity325 @entity532 developed, including multiple @entity397 and @entity548 . A new method of repair that incorporated double-thickness everted saphenous vein was used in 2 @entity1 , and safe arterial closure was achieved. There was 1 late fatality on postoperative day 36. Limb salvage was achieved in all @entity1 . CONCLUSIONS: @entity23984 complicating percutaneous suture closure is a challenging new problem for vascular surgeons and can result in @entity532 . Customary techniques that use saphenous vein patch or interposition grafting are not adequate in all circumstances. Successful outcome requires operative exploration in @entity1 with suspected @entity281 . Removal of the percutaneous suture closure device and debridement to normal arterial wall is recommended in all @entity1 with suspected femoral @entity23984 , based on positive intraoperative Gram stains or abnormal appearance of the adjacent femoral artery. Early success with an autologous bolstered repair is reported. Caution is advised when considering the use of a percutaneous suture closure device in @entity1 with comorbid conditions including @entity6 , @entity28 , and previously implanted devices.

XXXX associated with percutaneous suture closure: new technology, challenging complications.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes', 'diabetes mellitus'] @entity28 :: ('MESH:D009765', 'Disease') :: ['obesity'] @entity548 :: ('MESH:D006470', 'Disease') :: ['hemorrhage'] @entity23984 :: ('MESH:D004692', 'Disease') :: ['endarteritis', 'Femoral endarteritis'] @entity532 :: ('MESH:D003925', 'Disease') :: ['catastrophic complications'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection', 'arterial wall infections', 'arterial infections'] @entity397 :: ('MESH:D012421', 'Disease') :: ['anastomotic ruptures'] @entity325 :: ('MESH:D060085', 'Disease') :: ['polymicrobial infection'] @entity69586 :: ('MESH:D005266', 'Disease') :: ['Invasive femoral endarteritis'] @entity166 :: ('MESH:D003141', 'Disease') :: ['infectious complications']
@entity23984 :: (MESH:D004692,Disease) :: ['Femoral endarteritis']
